The future of oncology is rapidly shifting toward precision medicine and targeted cancer therapies. Among the most significant advancements is Olaparib 100mg and Olaparib 150mg Tablets, a breakthrough medication designed to help patients with specific genetic mutations fight cancer more effectively.
Cordium Pharmaceuticals Pvt Ltd is a reliable pharmaceutical manufacturer and global exporter committed to supplying high-quality oncology medicines to healthcare institutions, hospitals, distributors, and importers worldwide.
Our international network extends across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa, ensuring uninterrupted access to advanced cancer treatments.
What Are Olaparib 100mg & 150mg Tablets?
Olaparib is an oral anti-cancer medication belonging to a class of drugs called PARP (Poly ADP-Ribose Polymerase) inhibitors.
It is specifically developed for patients whose cancers are associated with BRCA gene mutations or other homologous recombination repair (HRR) abnormalities.
Unlike traditional chemotherapy, Olaparib selectively targets cancer cells while preserving many healthy cells.
Conditions Treated with Olaparib Tablets
Ovarian Cancer Management
Olaparib is widely used for:
- Recurrent ovarian cancer
- Advanced ovarian cancer maintenance therapy
- BRCA-positive ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
Breast Cancer Treatment
Prescribed for:
- HER2-negative breast cancer
- Germline BRCA-mutated breast cancer
Pancreatic Cancer Therapy
Used as maintenance treatment for metastatic pancreatic cancer after platinum-based chemotherapy.
Prostate Cancer Care
Recommended for:
- Metastatic castration-resistant prostate cancer (mCRPC)
- Patients with HRR gene mutations
Why Is Olaparib Considered a Breakthrough Therapy?
Cancer cells continuously repair themselves to survive. Olaparib interrupts this process by blocking PARP enzymes.
This leads to:
✔ DNA damage accumulation inside cancer cells
✔ Reduced tumor growth
✔ Delayed disease progression
✔ Improved long-term disease management
✔ Personalized cancer treatment approaches
This innovative mechanism has transformed cancer care worldwide.
Available Strengths
Olaparib 100mg Tablets
Suitable for:
- Personalized dosage adjustments
- Patients requiring flexible treatment regimens
- Physician-monitored oncology care
Olaparib 150mg Tablets
Commonly prescribed for:
- Standard maintenance protocols
- Long-term treatment plans
- Advanced cancer management
Always administer under oncologist supervision.
Advantages of Choosing Cordium Pharmaceuticals Pvt Ltd
As a trusted global pharmaceutical exporter, Cordium Pharmaceuticals Pvt Ltd offers:
Quality You Can Trust
- International quality manufacturing standards
- Stringent quality assurance procedures
- Reliable batch consistency
Global Distribution Expertise
- Timely international deliveries
- Export documentation support
- Regulatory assistance
Affordable Oncology Solutions
- Competitive pricing
- Sustainable supply chain
- Long-term business partnerships
Customer-Centric Approach
- Dedicated export team
- Fast inquiry response
- Customized supply solutions
Countries We Serve
We actively support oncology medicine supply in:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Europe & North America
🇬🇧 UK
🇺🇸 USA
Frequently Asked Questions
Is Olaparib a chemotherapy medicine?
No. Olaparib is a targeted therapy and belongs to the PARP inhibitor class.
Who is eligible for Olaparib treatment?
Patients diagnosed with specific BRCA or HRR gene mutations, as determined by healthcare professionals.
Is genetic testing required?
Yes. Genetic testing often helps determine whether Olaparib is an appropriate treatment option.
Can Olaparib be taken at home?
Since it is an oral medication, patients can take it at home under strict medical supervision.
About Cordium Pharmaceuticals Pvt Ltd
Cordium Pharmaceuticals Pvt Ltd is committed to expanding access to innovative oncology therapies through dependable manufacturing, ethical business practices, and a strong global supply network.
We support healthcare systems by delivering advanced cancer medicines that meet international quality expectations.
